
Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
Body Image and Sexual Health Challenges After Breast Cancer
2
What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma
3
Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery
4
What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?
5